Clinical Trials
4
Active:0
Completed:3
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 3
1 (100.0%)Real-life Observational Study of Cancer Pain Management With Methadone
Completed
- Conditions
- Cancer Pain
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Laboratoires Bouchara-Recordati
- Target Recruit Count
- 136
- Registration Number
- NCT05265442
- Locations
- π«π·
LBR, Puteaux, France
Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer
Withdrawn
- Conditions
- Prostate Cancer
- First Posted Date
- 2019-06-18
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Laboratoires Bouchara-Recordati
- Target Recruit Count
- 800
- Registration Number
- NCT03990194
Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH
Completed
- Conditions
- Benign Prostatic Hyperplasia
- First Posted Date
- 2017-06-07
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- Laboratoires Bouchara-Recordati
- Target Recruit Count
- 625
- Registration Number
- NCT03179670
- Locations
- π«π·
LBR, Puteaux, France
Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Laboratoires Bouchara-Recordati
- Target Recruit Count
- 146
- Registration Number
- NCT01793480
- Locations
- π«π·
Investigational Site 10, Amiens, France
π«π·Investigational Site 06, Bayonne, France
π«π·Investigational Site 13, Caen, France
News
No news found